Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee advances bill to fund research, training for psychedelic-assisted therapies
Summary
The Senate Committee on Health and Human Services advanced SB 10-42 to create a Mental Health Emerging Therapy Special Fund to support research, professional training and patient access for therapies including MDMA and psilocybin-assisted treatments, after extensive public testimony and attorney general review.
The Senate Committee on Health and Human Services on Feb. 10 advanced Senate Bill 10-42, a measure to create a special fund to support research, workforce training and patient access for emerging mental-health therapies including MDMA- and psilocybin-assisted psychotherapy.
Supporters told the committee the bill could expand access to treatments for people with treatment-resistant post-traumatic stress disorder and major depressive disorder. Lieutenant General Martin Steele, representing the Veteran Mental Health Leadership Coalition, said the therapies showed promise and urged passage. "I urge you to pass SB 10 42," Steele said.
The bill’s nut graf is…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
